Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Distinct Roles for Two Chromosome 1 Loci in Ethanol Withdrawal, Consumption, and Conditioned Place Preference.

Kozell LB, Denmark DL, Walter NAR, Buck KJ.

Front Genet. 2018 Aug 27;9:323. doi: 10.3389/fgene.2018.00323. eCollection 2018.

2.

A Systems Approach Implicates a Brain Mitochondrial Oxidative Homeostasis Co-expression Network in Genetic Vulnerability to Alcohol Withdrawal.

Walter NA, Denmark DL, Kozell LB, Buck KJ.

Front Genet. 2017 Jan 3;7:218. doi: 10.3389/fgene.2016.00218. eCollection 2016.

3.

Limbic circuitry activation in ethanol withdrawal is regulated by a chromosome 1 locus.

Buck KJ, Chen G, Kozell LB.

Alcohol. 2017 Feb;58:153-160. doi: 10.1016/j.alcohol.2016.09.030. Epub 2016 Dec 8.

4.

G Protein-Gated Inwardly Rectifying Potassium Channel Subunit 3 Knock-Out Mice Show Enhanced Ethanol Reward.

Tipps ME, Raybuck JD, Kozell LB, Lattal KM, Buck KJ.

Alcohol Clin Exp Res. 2016 Apr;40(4):857-64. doi: 10.1111/acer.13012. Epub 2016 Mar 25. Erratum in: Alcohol Clin Exp Res. 2016 Oct;40(10 ):2253.

5.

Novel MPDZ/MUPP1 transgenic and knockdown models confirm Mpdz's role in ethanol withdrawal and support its role in voluntary ethanol consumption.

Milner LC, Shirley RL, Kozell LB, Walter NA, Kruse LC, Komiyama NH, Grant SG, Buck KJ.

Addict Biol. 2015 Jan;20(1):143-7. doi: 10.1111/adb.12087. Epub 2013 Oct 10.

6.

Discovering genes involved in alcohol dependence and other alcohol responses: role of animal models.

Buck KJ, Milner LC, Denmark DL, Grant SG, Kozell LB.

Alcohol Res. 2012;34(3):367-74.

7.

Substantia nigra pars reticulata is crucially involved in barbiturate and ethanol withdrawal in mice.

Chen G, Kozell LB, Buck KJ.

Behav Brain Res. 2011 Mar 17;218(1):152-7. doi: 10.1016/j.bbr.2010.10.025. Epub 2010 Oct 23.

8.

Differential activation of limbic circuitry associated with chronic ethanol withdrawal in DBA/2J and C57BL/6J mice.

Chen G, Reilly MT, Kozell LB, Hitzemann R, Buck KJ.

Alcohol. 2009 Sep;43(6):411-20. doi: 10.1016/j.alcohol.2009.05.003.

9.
10.

Contribution of dopamine receptors to periaqueductal gray-mediated antinociception.

Meyer PJ, Morgan MM, Kozell LB, Ingram SL.

Psychopharmacology (Berl). 2009 Jun;204(3):531-40. doi: 10.1007/s00213-009-1482-y. Epub 2009 Feb 19.

11.

Involvement of the limbic basal ganglia in ethanol withdrawal convulsivity in mice is influenced by a chromosome 4 locus.

Chen G, Kozell LB, Hitzemann R, Buck KJ.

J Neurosci. 2008 Sep 24;28(39):9840-9. doi: 10.1523/JNEUROSCI.1713-08.2008.

12.

Multiple conductances are modulated by 5-HT receptor subtypes in rat subthalamic nucleus neurons.

Shen KZ, Kozell LB, Johnson SW.

Neuroscience. 2007 Sep 21;148(4):996-1003. Epub 2007 Jul 17.

13.

Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Putterman DB, Munhall AC, Kozell LB, Belknap JK, Johnson SW.

J Pharmacol Exp Ther. 2007 Oct;323(1):277-84. Epub 2007 Jul 27.

PMID:
17660384
14.

Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56(Lck).

Marracci GH, Marquardt WE, Strehlow A, McKeon GP, Gross J, Buck DC, Kozell LB, Bourdette DN.

Biochem Biophys Res Commun. 2006 Jun 9;344(3):963-71. Epub 2006 Apr 5.

PMID:
16631599
15.
16.

Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor.

Torvinen M, Kozell LB, Neve KA, Agnati LF, Fuxe K.

J Mol Neurosci. 2004;24(2):173-80.

PMID:
15456930
18.

Regulation of dopamine D(1) receptor trafficking by protein kinase A-dependent phosphorylation.

Mason JN, Kozell LB, Neve KA.

Mol Pharmacol. 2002 Apr;61(4):806-16.

PMID:
11901220
19.
20.

Dopamine D4 receptor-deficient mice display cortical hyperexcitability.

Rubinstein M, Cepeda C, Hurst RS, Flores-Hernandez J, Ariano MA, Falzone TL, Kozell LB, Meshul CK, Bunzow JR, Low MJ, Levine MS, Grandy DK.

J Neurosci. 2001 Jun 1;21(11):3756-63.

21.

Constitutive activity of a chimeric D2/D1 dopamine receptor.

Kozell LB, Neve KA.

Mol Pharmacol. 1997 Dec;52(6):1137-49.

PMID:
9396784
22.

Drug-induced up-regulation of dopamine D2 receptors on cultured cells.

Starr S, Kozell LB, Neve KA.

J Neurochem. 1995 Aug;65(2):569-77.

PMID:
7616211
23.

Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.

Kozell LB, Machida CA, Neve RL, Neve KA.

J Biol Chem. 1994 Dec 2;269(48):30299-306.

24.

Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds.

Shields AF, Graham MM, Kozawa SM, Kozell LB, Link JM, Swenson ER, Spence AM, Bassingthwaighte JB, Krohn KA.

J Nucl Med. 1992 Apr;33(4):581-4.

25.

Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene.

Machida CA, Searles RP, Nipper V, Brown JA, Kozell LB, Neve KA.

Mol Pharmacol. 1992 Apr;41(4):652-9.

PMID:
1533268

Supplemental Content

Loading ...
Support Center